Harbin Medisan Pharmaceuticals Co., Ltd. logo

Harbin Medisan Pharmaceuticals Co., Ltd. (002900)

Market Closed
11 Aug, 06:57
XSHE XSHE
¥
14. 58
-0.25
-1.6858%
¥
4.59B Market Cap
- P/E Ratio
700% Div Yield
62.57M Volume
0 Eps
¥ 14.83
Previous Close
Add Transaction
Day Range
12.26 15.8
Year Range
8.93 16.46
Want to track 002900 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

002900 closed today lower at ¥14.58, a decrease of -1.6858% from yesterday's close, completing a monthly increase of 60.396% or ¥5.49. Over the past 12 months, 002900 stock gained 16.0828%.
002900 is not paying dividends to its shareholders.
The last earnings report, released on May 16, 2025, missed the consensus estimates by -0.0912%. On average, the company has fell short of earnings expectations by -0.0106%, based on the last three reports.
Harbin Medisan Pharmaceuticals Co., Ltd. has completed 1 stock splits, with the recent split occurring on Jun 13, 2018.
The company's stock is traded on one exchange.

002900 Chart

People also search for

Dr Corp Ltd.
¥ 23.35
-2.4237%
Sunvim Group Co., Ltd.
¥ 11.72
-3.3003%
Tibet Gaozheng Explosive Co., Ltd.
¥ 58.61
-1.6281%
Innovative Medical Management Co., Ltd.
¥ 21.24
-3.1022%
Henan Liliang Diamond Co., Ltd.
¥ 59.21
-1.366%

Harbin Medisan Pharmaceuticals Co., Ltd. (002900) FAQ

What is the stock price today?

The current price is ¥14.58.

On which exchange is it traded?

Harbin Medisan Pharmaceuticals Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 002900.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 700%.

What is its market cap?

As of today, the market cap is 4.59B.

Has Harbin Medisan Pharmaceuticals Co., Ltd. ever had a stock split?

Harbin Medisan Pharmaceuticals Co., Ltd. had 1 splits and the recent split was on Jun 13, 2018.

Harbin Medisan Pharmaceuticals Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Jian Fei Qin CEO
XSHE Exchange
CNE1000032V9 ISIN
CN Country
2,522 Employees
29 May 2025 Last Dividend
13 Jun 2018 Last Split
- IPO Date

Overview

Harbin Medisan Pharmaceutical Co., Ltd., founded in 1996 and headquartered in Harbin, China, is deeply entrenched in the pharmaceutical industry, focusing on the research, development, production, and sale of pharmaceutical products and medical devices within China. The company has carved a niche for itself by offering a wide range of pharmaceutical products catering to various health needs, alongside its venture into the cosmetics market. As a testament to its expansive approach, Harbin Medisan not only emphasizes the production of essential medication but also ensures to cover a broad spectrum of health-related concerns through its diversified product lineup.

Products and Services

Harbin Medisan Pharmaceutical Co., Ltd. offers a comprehensive portfolio of products and services designed to meet a wide variety of health care needs, including:

  • Nervous System Drugs: These are formulated to address various neurological conditions, helping in the management of diseases affecting the nervous system.
  • Cardiovascular System Medications: Focused on treating ailments associated with the heart and blood vessels, these drugs are vital for those suffering from hypertension, heart disease, and other related conditions.
  • Musculoskeletal System Drugs: Aimed at treating conditions that affect muscles, bones, and joints, these medications are essential for patients suffering from arthritis, osteoporosis, and other musculoskeletal disorders.
  • Systemic Anti-infective Drugs: These medications are designed to combat infections, providing a broad spectrum of action against various pathogens.
  • Basic Infusions: Essential for hydration and electrolyte balance, these solutions are used in hospitals and clinics for patient care.
  • Nutritional Infusion Solutions: These are specialized infusions designed to provide necessary nutrients to patients who are unable to consume food orally.
  • Anti-tumor and Immunomodulators: This category includes drugs used in the treatment of cancer and medications designed to modulate the immune system.
  • Digestive Tract and Metabolism Medications: These products focus on the digestive system and metabolic processes, aiding in the treatment and management of gastrointestinal and metabolic disorders.
  • Cosmetics: Extending its scope beyond pharmaceuticals, Harbin Medisan also produces and sells beauty and personal care products, catering to a variety of cosmetic needs.

Contact Information

Address: Beijing Road, Harbin, China, 150025
Phone: 86 45 1573 55689